Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Muhlenkamp & Co. Inc. purchased a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the second quarter, HoldingsChannel.com reports. The firm purchased 129,569 shares of the biopharmaceutical company’s stock, valued at approximately $8,286,000. Bristol-Myers Squibb accounts for 2.9% of Muhlenkamp & Co. Inc.’s holdings, making the stock its 17th largest holding. Other hedge […]
Marcum Wealth LLC boosted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 14.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,234 shares of the biopharmaceutical company’s stock after acquiring an additional 1,583 shares during the period. Marcum […]
Marcum Wealth LLC raised its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 14.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,234 shares of the biopharmaceutical company’s stock after buying an additional 1,583 shares during the quarter. […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) announced a quarterly dividend on Wednesday, September 20th, Zacks reports. Shareholders of record on Friday, October 6th will be given a dividend of 0.57 per share by the biopharmaceutical company on Wednesday, November 1st. This represents a $2.28 dividend on an annualized basis and a dividend yield of […]
First PREMIER Bank decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 19.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,708 shares of the biopharmaceutical company’s stock after selling 2,745 shares during the quarter. First PREMIER Bank’s holdings in Bristol-Myers […]